Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurugram, India

Brief profile of  Dr. Arvinder S. Soin
Group Chairman & Chief Liver Transplant Surgeon, Medanta Institute of Liver Transplantation and Regenerative Medicine, Gurugram & Lucknow.
–       Heads India’s largest and most successful liver transplant center
–        Surgical Innovator, Researcher, Healthcare Investor
–       One of the India’s foremost healthcare influencers
–       One of the most followed physicians on Twitter globally, with nearly 100K followers
Qualifications: MBBS (AIIMS), MS (AIIMS), FRCS (Glas, Edin), FRCS (Intercollegiate – Transplant Surg)
Pioneering Contribution to Liver Transplantation in India
·       Recognized globally for pioneering liver transplantation and live donor liver transplant (LDLT) in India, and putting India on the global liver transplant map
·       Performed the first successful liver transplant in India on Nov 6, 1998 (adult DDLT)      
·       Performed the country’s first successful pediatric liver Transplant, Nov 15, 1998        
·       Performed the highest – > 3800 liver transplants in India including 350 pediatric transplants; with > 90% success.
·       Credited with most of the firsts in liver transplant in India – first left lobe, right lobe, dual lobe, swap, simultaneous LDLT + LDKT, ABO-i LDLT, domino, smallest & oldest recipient etc.
·       Trained over 120 liver transplant fellows, who now run more than 60 centers in India
·       Trained visiting transplant doctors and paramedics from more than 40 centers in India 
Publications, lectures
·       Over 200 original research articles and book chapters. Delivered over 1200 lectures globally. (
·       Editor of Elsevier book entitled ‘Liver Transplantation’, 2012
Awards, orations, honors
·       Padma Shri (2010), 9 other National and 3 international awards
·       Awarded and delivered 16 Orations
·       Honorary Fellowship, KGMC, Lucknow, 2007
·       Visiting Professor, KEM College and Hospital, Mumbai, 2009 onwards
·       Primary investigator:
o   National multi-center RCT on TCZ in COVID-19 (published as first author in The Lancet Resp Med 2021)
o   International multi-center RCTs (resulted in 7 publications so far)
§  Protocol CRAD001H2307 (Everolimus – 2014-17)
§  Protocol CLJN452A2202 (NASH –LJN452: 2018-2021)
·       Supervised 108 clinical research projects
·       Supervised 3 PhDs – ‘Nutrition in Liver Transplantation’, ‘Navigational Liver Surgery’, IIT(D), ‘Model for post-LT outcome’
Teaching, examining, conferences, workshops, consensus groups
·       Surgical Tutor – 1. AIIMS, New Delhi, 2. Cambridge University, UK
·       Examiner: 2 Royal Colleges (UK) – FRCS, MRCS; DNB GI Surgery, FNB Liver Transplant
·       Organizing Chairperson: 25 liver congresses and workshops (1994-2021)
·       Consensus groups/conferences: Group In charge -3, member -6 (includes APASL, INASL, ILTS, ERAS, International minimally invasive liver surgery group)
Innovation in Healthcare
·       Several surgical techniques – published 2000-2021; brought NMP to India from Oxford Univ.
·       Founder, self-diagnostic and monitoring app ‘LiverPedia’ 2016-18
·       Founder, ‘NEOLIVER’ Lab – projects: hepatic organoids, and humanized mice models of HCC
·       Scientific Advisor and Investor, Zebra Medical Vision (AI company), Israel
·       Scientific Advisor and Investor, Y Trap. Inc. (Biotech company), USA
Positions in Professional Organizations
·       Executive Council Member, International Liver Transplant Society, 2022 onwards
·       Founder President, Liver Transplant Society of India 2018-19
·       Executive Committee Member – IASG – 4 years
·       Vice-President, Indian Society of Transplantation, 3 years
·       Member, Vice-Chair, then Chair, Membership & Comm. Committee, International  Liver Transplantation Society – 4 years
·       Executive Committee Member, International Live Donor Liver Transplant (iLDLT) Group 2017- present